Article
Precision-cut liver slices as a model for evaluating therapeutic agents against hepatitis B and delta viruses
2025-12-06
Abstract excerpt
<h4>Background: </h4> Developing new therapeutic strategies against hepatitis B virus (HBV) and hepatitis delta virus (HDV) is essential to cure these infections. Yet evaluation of host-targeting agents (HTAs) with in vitro/in vivo models remains challenging. Therefore, we assessed precision-cut liver slices (PCLS) as an HBV/HDV co-infection model to study virus-host interactions and HTAs. <h4>Methods:</h4> We gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 73dca88c-b562-5439-a19a-bb25742ffef5
- DOI
- 10.64898/2025.12.06.692712
